MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.0675
+0.0015 (2.27%)
Aug 7, 2026, 3:02 PM EST
MariMed Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 27 | 37 | 44 | 103 | 121 | 289 | |
Market Cap Growth | -34.11% | -15.63% | -57.26% | -14.51% | -58.11% | 101.45% |
Enterprise Value | 115 | 130 | 141 | 171 | 178 | 324 |
Last Close Price | 0.07 | 0.09 | 0.12 | 0.27 | 0.36 | 0.86 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 8.98 | 39.95 |
Forward PE | - | 20.66 | 20.66 | 20.66 | 6.48 | 21.63 |
PS Ratio | 0.17 | 0.23 | 0.28 | 0.70 | 0.90 | 2.38 |
PB Ratio | 0.51 | 0.58 | 0.57 | 1.16 | 1.27 | 3.90 |
P/TBV Ratio | 3.39 | 3.50 | 1.71 | 2.43 | 3.31 | 8.10 |
P/FCF Ratio | 4.46 | 5.71 | - | - | - | 16.05 |
P/OCF Ratio | 3.69 | 4.84 | 6.51 | 13.07 | 16.54 | 8.05 |
PEG Ratio | - | 0.48 | 0.48 | 0.48 | 0.48 | 0.72 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.72 | 0.81 | 0.90 | 1.15 | 1.33 | 2.67 |
EV/EBITDA Ratio | 9.07 | 14.16 | 9.79 | 7.24 | 6.83 | 10.93 |
EV/EBIT Ratio | - | - | 39.63 | 11.36 | 8.34 | 12.06 |
EV/FCF Ratio | 19.00 | 19.91 | - | - | - | 18.02 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.71 | 1.32 | 1.14 | 0.90 | 0.38 | 0.33 |
Debt / EBITDA Ratio | 7.17 | 7.55 | 5.37 | 3.14 | 1.32 | 0.79 |
Debt / FCF Ratio | 15.01 | 13.08 | - | - | - | 1.36 |
Net Debt / Equity Ratio | 1.56 | 1.18 | 1.05 | 0.74 | 0.27 | -0.07 |
Net Debt / EBITDA Ratio | 7.86 | 8.33 | 5.63 | 2.77 | 1.00 | -0.19 |
Net Debt / FCF Ratio | 13.70 | 11.72 | -15.69 | -5.35 | -5.38 | -0.31 |
Asset Turnover | 0.79 | 0.78 | 0.78 | 0.85 | 0.97 | 1.22 |
Inventory Turnover | 2.69 | 2.91 | 3.24 | 3.69 | 4.79 | 6.65 |
Quick Ratio | 0.27 | 0.31 | 0.33 | 0.73 | 0.56 | 1.22 |
Current Ratio | 0.95 | 1.00 | 1.07 | 1.67 | 1.67 | 1.64 |
Return on Equity (ROE) | -20.01% | -20.32% | -14.93% | -17.40% | 16.11% | 15.74% |
Return on Assets (ROA) | -0.38% | -0.71% | 1.10% | 5.41% | 9.68% | 16.82% |
Return on Invested Capital (ROIC) | -0.89% | -1.56% | 2.27% | 10.95% | 15.71% | 13.16% |
Return on Capital Employed (ROCE) | -0.90% | -1.60% | 2.30% | 9.10% | 17.00% | 28.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -47.03% | -38.86% | -28.22% | -15.51% | 11.14% | 2.50% |
FCF Yield | 22.40% | 17.52% | -11.71% | -11.82% | -3.99% | 6.23% |
Buyback Yield / Dilution | -3.38% | -2.90% | -4.33% | 4.44% | -2.12% | -14.88% |